Art. 39 Regulation (EU) 2021/963

Obligation of the veterinarian responsible in relation to the documentation of the status of an equine animal as intended for or excluded from slaughter for human consumption in the single lifetime identification document

In forcesince 10 Jun 2021
1.

Prior to any treatment with a veterinary medicinal product authorised in accordance with Article 8(4) of Regulation (EU) 2019/6, or a medicinal product applied in accordance with Article 112(4) thereof, or containing a substance included in the list of substances established in accordance with Article 115(5) thereof, the veterinarian responsible shall ascertain the status of the animal as intended for or excluded from slaughter for human consumption documented in the single lifetime identification document, and where access is provided, in the computer database.

2.

Where an indication concerning an equine animal being intended for slaughter for human consumption requires the administration of a medicinal product in accordance with Article 112(4) of Regulation (EU) 2019/6 and the operator has agreed to such treatment on behalf of the owner, the veterinarian responsible shall ensure that the equine animal concerned is prior to the treatment irreversibly declared as not intended for slaughter for human consumption by completing and signing Part II of Section II of the model identification document for equine animals set out in Part 1 of Annex II to this Regulation.

3.

Where an indication concerning an equine animal intended for slaughter for human consumption requires the administration of a medicinal product containing a substance included in the list set out in Commission Regulation (EC) No 1950/2006 and the operator has agreed to such treatment on behalf of the owner, the veterinarian responsible shall enter the requisite details of the medicinal product containing such substances in Part III of Section II of the model identification document for equine animals set out in Part 1 of Annex II to this Regulation.

The veterinarian responsible shall enter the date of last administration, as prescribed, of that medicinal product and shall inform the operator of the date when the withdrawal period of six months will lapse.